Winrevair | FAMHP

Active substance	Sotatercept (MK-7962)
Holder	MSD
Status	Running
Indication	Adult patients with Pulmonary Arterial Hypertension (PAH) with WHO Functional Class (FC) II/III or FC IV.
Public documents	Approbation Approbation amendment - 1 Approbation amendment - 2
	Information for the patient Information for the patient - amendment - 1 Information for the patient - amendment - 2
	Informed consent Informed consent - amendment - 1 Informed consent - amendment - 2
Last update	01/09/2026